AdventHealthMD
The AdventHealth Nicholson Center recently earned the Comprehensive Accredited Educational Institution (AEI) accreditation from the American College of Surgeons (ACS).
As the health care industry continues to grapple with shortages of clinicians on a national scale, the city of Palm Coast is home to an innovative solution: a state-of-the-art facility that has become...
In the presence of local and national dignitaries, students, alumni, and faculty, AdventHealth University inaugurated C. Josef Ghosn, EdD, FACHE, its third president and CEO.
Several cancers can cause peritoneal carcinomatosis, including peritoneal mesothelioma and primary peritoneal cancer as well as secondary cancers that have metastasized from the...
Nurses face workplace stressors that can impact their mental health and job satisfaction, resulting in burnout, job dissatisfaction and turnover. In addition to negatively impacting their personal...
In the U.S., Black women are three times more likely to die from a pregnancy-related cause than white women, and their breast cancer mortality rate is 40% higher.
Sadly, these startling statistics...
A genetic test, originally conducted to help better understand her daughter's diagnosis, revealed Samantha Arceneaux carries a genetic variant that virtually guarantees she will develop an aggressive...
Under the leadership of investigator Guru Sonpavde, MD, AdventHealth’s Clinical Research Unit (CRU), a collaborative between the AdventHealth Cancer Institute and AdventHealth Research Institute, is...
The AdventHealth Research Institute recently launched two new clinical studies to better understand and address the needs of healthcare employees who work night shifts.
In January 2024, AdventHealth Celebration neurotologist Michael Seidman, MD, FACS, became the first in Florida and the Southeast to complete a robotics-assisted cochlear implant procedure using the...
Avertix’s Guardian™ System, the first and only implantable device approved by the U.S. Food and Drug Administration (FDA) for use in patients who have had prior acute coronary syndrome (ACS) events...
Karen Corbin, PhD, RD shares her experience teaching other scientist how to effectively communicate their findings to health care professionals.
The CheckMate 901 Phase III clinical trial results, recently published in the New England Journal of Medicine, found that combining the programmed death 1 (PD1) inhibitor immunotherapy nivolumab with...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.